We’re delighted to announce that Vorpal Technologies is starting 2022 as part of a larger organization, MCRA LLC (https://www.mcra.com/), enabling us to increase our capabilities and reach in the MedTech field. MCRA, headquartered in Washington, DC, is a leading regulatory, clinical and reimbursement consulting firm and full-service CRO with three offices in the US and one in Europe. This merger marks MCRA’s first expansion into Asia Pacific.
Vorpal is the leader in Japan for new category MedTech shonin approvals, recently securing three approvals in a single week to close out a successful 2021. This merger enables Vorpal to accelerate expansion, meeting demand as the premier portal into Japan for worldwide MedTech innovations.